Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) has shared an announcement.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has provided an update on the bankruptcy liquidation of its 55%-owned subsidiary, Tianjin Shin Poong Pharmaceutical Co., Ltd. As of the latest update, there have been no significant developments in the bankruptcy proceedings that would impact the company’s financial position. The company remains committed to monitoring the situation closely, maintaining communication with relevant parties, and safeguarding shareholder interests. Monthly updates will continue to be provided in accordance with listing requirements.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, is a company incorporated in the People’s Republic of China. It operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products.
Find detailed analytics on 2TZ stock on TipRanks’ Stock Analysis page.